Source: Eur Respir J, 59 (2) 2003979; 10.1183/13993003.03979-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Tomoko Nakanishi, Agustin Cerani, Vincenzo Forgetta, Sirui Zhou, Richard J. Allen, Olivia C. Leavy, Masaru Koido, Deborah Assayag, R. Gisli Jenkins, Louise V. Wain, Ivana V. Yang, G. Mark Lathrop, Paul J. Wolters, David A. Schwartz, J. Brent Richards. Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study. Eur Respir J, 59 (2) 2003979; 10.1183/13993003.03979-2020

Member's Comments

No comment yet.

Related content which might interest you: Inflammation biomarkers and risk of pulmonary hypertension: a Mendelian randomization study Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 A BTNL2 gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 148s Year: 2006 Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 CFTR and risk of pulmonary arterial hypertension: a case report and mendelian randomization study Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Elevated pulmonary vascular resistance is associated with increased risk of death in IPF Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Systemic inflammation, genetic susceptibility and lung function Source: Eur Respir J 2008; 32: 92-97 Year: 2008 Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult Source: Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019 Year: 2020 Reduced heart rate variability is associated with increased level of serum ICAM-1 in patients with sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis Source: Eur Respir J, 55 (4) 1902361; 10.1183/13993003.02361-2019 Year: 2020 Elevated leukocyte count predicts survival in patients with idiopathic pulmonary fibrosis: analysis from the Swedish and Japanese cohorts Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002 IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021